Zambia and Indian Sign Deal to Produce Medicines Locally

The Government of Zambia has signed a Joint Venture agreement with India’s Akums Drugs and Pharmaceuticals Limited to establish a pharmaceutical manufacturing plant in Zambia that will produce approximately 150 essential medicines locally.

The agreement was finalized on Thursday by a Zambian delegation led by Deputy Secretary to the Cabinet for Finance and Economic Development, Dr. Siazongo Siakalenge. 

The delegation also included Ministry of Justice Permanent Secretary – Legal, Ms. Mwenya Bwalya, and Ministry of Health Permanent Secretary – Technical Services, Dr. Kennedy Lishimpi.

The plant, to be constructed with support from the Zambia Development Agency (ZDA) and the Zambia Medicines and Medical Supplies Agency (ZAMMSA), will be the first Akums facility outside India. 

A groundbreaking ceremony is scheduled for September and will be officiated by President Hakainde Hichilema.

Dr. Siakalenge said the project will significantly reduce Zambia’s reliance on imported drugs and ensure a steady supply of essential medicines. 

“Akums will localize the production of drugs and medicines. Close to 150 products will be made in Zambia, making us almost self-sufficient,” he said.

Akums International Business President Ashok Saroha said the move marks a major step in the company’s global expansion and a commitment to supporting healthcare in Zambia. 

“This is a special moment for us. It’s not just business—it’s about helping Zambia become self-reliant in essential medicines,” he said.

Dr. Lishimpi, who signed on behalf of the Zambian government, described the agreement as a “game changer” that will improve access to affordable, quality medicines in the country.

The partnership follows two years of negotiations between the Zambian government and Akums.